GSK struggles to convince market it can deliver on pipeline plans
US hedge fund shorts drugmaker as shares trade below price of a decade ago

Apr 16, 2025 0
Apr 16, 2025 0
Apr 16, 2025 0
Apr 13, 2025 0
Apr 10, 2025 0
Apr 10, 2025 0
Apr 10, 2025 0
Apr 16, 2025 0
Apr 16, 2025 0
Apr 15, 2025 0
Apr 15, 2025 0
Apr 14, 2025 0
Apr 14, 2025 0
Apr 15, 2025 0
Apr 15, 2025 0
Apr 15, 2025 0
Apr 15, 2025 0
Or register with email
Feb 9, 2025 0
Feb 10, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 13, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.